Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bipolar I Disorder, Manic or Mixed”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00606281
What this trial is testing

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 258
Large-scale testing (Phase 3)Study completedNCT00249236
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar DisorderManic Episode
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 291
Large-scale testing (Phase 3)Looking for participantsNCT06929273
What this trial is testing

Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

Who this might be right for
Bipolar Disorder Type I With Mania
Bristol-Myers Squibb 450
Large-scale testing (Phase 3)Study completedNCT06462612
What this trial is testing

Study of Lumateperone in the Treatment of Patients With Bipolar Mania

Who this might be right for
Bipolar Disorder, Manic
Intra-Cellular Therapies, Inc. 351
Large-scale testing (Phase 3)Study completedNCT00606229
What this trial is testing

Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 41
Large-scale testing (Phase 3)Study completedNCT06419582
What this trial is testing

BHV-7000 Acute Treatment of Bipolar Mania

Who this might be right for
Bipolar Disorder
Biohaven Therapeutics Ltd. 274
Large-scale testing (Phase 3)Study completedNCT00110461
What this trial is testing

Aripiprazole in Children and Adolescents With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 296
Post-approval studies (Phase 4)Study completedNCT00261443
What this trial is testing

Aripiprazole (Abilify) in Patients With Bipolar Mania

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,270
Large-scale testing (Phase 3)Looking for participantsNCT06951698
What this trial is testing

Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

Who this might be right for
Bipolar-I Disorder With Mania or Mania With Mixed Features
Bristol-Myers Squibb 274
Post-approval studies (Phase 4)Study completedNCT00350857
What this trial is testing

The Young Adult and Pediatric Bipolar Study

Who this might be right for
Bipolar I Disorder
Validus Pharmaceuticals 161
Large-scale testing (Phase 3)Study completedNCT00257166
What this trial is testing

Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)

Who this might be right for
Bipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 238
Large-scale testing (Phase 3)Study completedNCT00195767
What this trial is testing

Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents

Who this might be right for
Bipolar I Disorder, Manic or Mixed
Abbott 150
Large-scale testing (Phase 3)Study completedNCT00606320
What this trial is testing

A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 59
Large-scale testing (Phase 3)Study completedNCT00606177
What this trial is testing

A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 99
Large-scale testing (Phase 3)Study completedNCT06462586
What this trial is testing

Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania

Who this might be right for
Bipolar Disorder, Manic
Intra-Cellular Therapies, Inc. 354
Post-approval studies (Phase 4)Study completedNCT00982020
What this trial is testing

Study in Adolescents With Schizophrenia or Bipolar Disorder

Who this might be right for
Bipolar I DisorderSchizophrenia
Eli Lilly and Company 203
Large-scale testing (Phase 3)WithdrawnNCT01117220
What this trial is testing

Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)

Who this might be right for
Bipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Large-scale testing (Phase 3)Study completedNCT03573297
What this trial is testing

A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

Who this might be right for
Bipolar I DisorderManiaDepression
AbbVie 901
Large-scale testing (Phase 3)Study completedNCT01349907
What this trial is testing

Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)

Who this might be right for
Bipolar Disorder
Organon and Co 322
Large-scale testing (Phase 3)Study completedNCT00490971
What this trial is testing

Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 768
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation